Bladder cancer symptoms often go unnoticed until it's too late. Learn the warning signs most people ignore and how early ...

Discover a study exploring novel drug combinations and genetic insights transforming advanced bladder cancer treatment.

AstraZeneca receives CDSCO approval for Durvalumab, a new treatment for muscle-invasive bladder cancer in India. This marks a ...

A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the ...

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...

AstraZeneca (LSE:AZN) received EU approval for its cancer treatment Imfinzi, marking a significant product-related milestone.

The approval allows the company to market Imfinzi 120 mg/2.4 ml and 500 mg/10 ml in combination with gemcitabine and ...

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...

Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...

Bladder cancer may be scary but it will help to know that depending on the stage of cancer treatment will help control or ...

The most common symptom of bladder cancer is painless blood in urine. It’s more common in smokers and those exposed to ...

Beat bladder cancer with early detection! Expert insights reveal how a multidisciplinary approach can improve treatment ...